الجمعة, يونيو 26, 2026
الجمعة, يونيو 26, 2026
Home » RCI: Weight-loss drug approved to treat sleep apnea in Canada

RCI: Weight-loss drug approved to treat sleep apnea in Canada

by admin

 

RCI / Nicole Ireland (new window) · The Canadian Press

Health Canada has approved weight-loss drug Zepbound for treating obstructive sleep apnea in adults with obesity.

The department confirmed that the authorization granted on June 11 makes Zepbound the only GLP-1 drug in Canada approved (new window) for the sleep disorder that causes people to stop breathing temporarily because their upper airway is blocked….

To read the full article on the official website, click here.

You may also like

Editor-in-Chief: Nabil El-bkaili

CANADAVOICE is a free website  officially registered in NS / Canada.

 We are talking about CANADA’S international relations and their repercussions on

peace in the world.

 We care about matters related to asylum ,  refugees , immigration and their role in the development of CANADA.

We care about the economic and Culture movement and living in CANADA and the economic activity and its development in NOVA  SCOTIA and all Canadian provinces.

 CANADA VOICE is THE VOICE OF CANADA to the world

Published By : 4381689 CANADA VOICE \ EPUBLISHING \ NEWS – MEDIA WEBSITE

Tegistry id 438173 NS-HALIFAX

 

هذا الموقع مجاني ولا يخضع لاية رسوم

This website is free and does not incur any fees

Email: nelbkaili@yahoo.com 

 

Editor-in-Chief : Nabil El-bkaili
-
00:00
00:00
Update Required Flash plugin
-
00:00
00:00